Alkeus Pharmaceuticals Announces Presentation of a TEASE-3
CAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc. today announced the presentation of interim data from its ...
Read moreCAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc. today announced the presentation of interim data from its ...
Read moreAll three patients treated for two years or more have remained free of symptoms and disease progression while taking gildeuretinol.TEASE-3 ...
Read morePrimary endpoint met, demonstrating a 21% slowing (p<0.001) in the growth rate of atrophic retinal lesions compared to the untreated ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.